|Articles|November 26, 2014
- Immunotherapy (Issue 4)
- Volume 4
- Issue 1
Potential Immunotherapies for Head and Neck Cancers
Author(s)Barbara Burtness, MD
Barbara Burtness, MD, discusses potential immunotherapy agents that may assist in the treatment of head and neck cancers.
Barbara Burtness, MD, Clinical Research Program Leader, Head and Neck Cancers Program,Co-Director, Developmental Therapeutics Research Program,Professor of Medicine (Medical Oncology), Yale Cancer Center, discusses potential immunotherapy agents that may assist in the treatment of head and neck cancers.
<<<
Articles in this issue
about 11 years ago
To Combine or Sequence Anti-PD-1 and Anti-PD-L1 in Questionabout 11 years ago
Programs Prepare for Immuno-Oncology in Clinical Settingabout 11 years ago
Right Patient for Immunotherapy in NSCLC Exploredabout 11 years ago
Weight May Affect Toxicity of Immunotherapiesabout 11 years ago
Adverse Events Associated With Immunotherapy in Lung Cancerabout 11 years ago
Immunotherapy Potential Option in Mesothelioma Treatmentabout 11 years ago
Immunotherapies for Prostate CancerRelated Content
Advertisement
